Pharmacy Report Archives - Page 35 of 150 - Becker's Hospital Review

Congress mulls PBM reforms | FDA adds liver injury warning for Veozah | Cancer drug shortage did not affect mortality: Study | Oral GLP-1 for weight loss: 4 notes

December 18, 2024 BHR Newsletter 1. Weight loss drugs ranked by recent price changes Full story 2. Congress' healthcare package: Key wins for hospitals, telehealth and physician pay Full story 3. FDA adds liver injury warning for Veozah Full story…

Outpatient pharmacy costs rise | Mark Cuban helps MultiCare save $1M | Sanofi sues HRSA over 340B rebate plan | FDA fast tracks flu, COVID shots | Mass. drugmaker to cut 65% of staff

December 17, 2024 BHR Newsletter 1. Insurer stock prices fall after Trump pledges to 'knock out middlemen' Full story 2. Outpatient pharmacy costs outpace total spend by 52% Full story 3. Sanofi sues HRSA after 340B rebate model warning Full…

Hospital pharmacy in 2025: ASHP | 233K antidepressant bottles recalled | GLP-1 barriers break down | FDA warns of injury risk with liver disease drug | What's next for patient care? 96 healthcare execs answer

December 16, 2024 BHR Newsletter 1. GLP-1 barriers begin to break down Full story 2. FDA recalls 233,000 bottles of antidepressant Full story 3. What pharmacy leaders should know heading into 2025: ASHP Full story 4. Rare diseases can be…

Bill targets joint PBM-pharmacy ownership | Carilion taps pharmacist as hospital president | Trump's FTC pick: 6 notes | Infant RSV vaccine trials on hold | 10 systems seeking pharmacy leaders

December 12, 2024 BHR Newsletter 1. Lawmakers push for insurers to divest pharmacies: 6 notes Full story 2. Infant RSV vaccine trials on hold: FDA Full story 3. Carilion taps pharmacist as president of 2 hospitals Full story 4. More data,…

Albertsons sues Kroger over failed merger | Walgreens weighs PE takeover: Report | Ultra high-cost drugs + hospital pharmacies: 5 notes | The harms of hospital drug testing | Eli Lilly to test GLP-1s for addiction

December 11, 2024 BHR Newsletter 1. Albertsons sues Kroger over failed merger Full story 2. Walgreens eyes private equity sale: WSJ report Full story 3. Ultra high-cost drugs to weigh on pharmacy finances: 5 things to know Full story 4. Prisma…

20 new drug shortages | Cedars-Sinai's plan to grow pharmacy tech workforce | Zepbound fills jump 300% | Blue Shield Calif. eyes $500M in annual drug savings | SCOTUS upholds 340B law in Ark.

December 10, 2024 BHR Newsletter 1. 20 drugs now in shortage Full story 2. Zepbound fills increase 300% this year: GoodRx Full story 3. Cedars-Sinai's plan to grow the pharmacy technician workforce Full story 4. Reassuring patients 'they're not alone': How…

Mark Cuban's latest system partner | 11 drugmakers rank among 'best-managed' | US bolsters IV inventory | New cancer drug approved | 5 notes on pharmacy deserts

December 9, 2024 BHR Newsletter 1. Penn Medicine partners with Mark Cuban's drug company Full story 2. 10 drugmakers among best-managed healthcare cos. Full story 3. Feds secure IV fluids from South Korea Full story 4. Rare disease patients need better care pathways.…

6 new GLP-1 findings | Calif. system settles drug error lawsuit | 2 gene therapy makers join CMS model | IV containers in short supply: FDA | CVS plans $2.5B bond sale

December 5, 2024 BHR Newsletter 1. CMS partners with 2 companies on sickle cell therapies Full story 2. UC Regents reaches $15M settlement over medication error: 5 things to know Full story 3. 6 GLP-1 study findings to know Full…

UnitedHealthcare CEO fatally shot | Pharmacy leaders' focus for next 3 years | Cuban defends disruption status | 1 in 3 pharmacies closed since 2010 | Zepbound eclipses Wegovy in weight loss results

December 4, 2024 BHR Newsletter 1. UnitedHealthcare CEO fatally shot in New York City Full story 2. Zepbound outperforms Wegovy for weight loss: Study Full story 3. US negotiated drug prices still higher than other countries: Study Full story 4.…

Diabetes group: Avoid compounded GLP-1s | 56% of pharmacists say AI will replace jobs | CVS taps pharmacy chief | Chicago system to upgrade specialty pharmacy | Va. system CEO to exit

December 3, 2024 BHR Newsletter 1. Diabetes group recommends against compounded GLP-1s Full story 2. Americans seeking new jobs reaches decade high: 5 things to know Full story 3. Ozempic is becoming cheaper Full story 4. Rare diseases can be…